← Back to RANI

Rani Therapeutics Holdings, Inc. - Class A Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 13/08/2026Mar 2026Filed 15/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 13/08/2026Mar 2025Filed 15/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 07/08/2025Mar 2024Filed 13/05/2025
$1.7$1.7$0$0$0.2$0$0$0
−$7.4−$7−$5.4−$6.7−$7.3−$6.8−$6.8−$7.5
−$0.04−$0.04−$0.12−$0.18−$0.22−$0.24−$0.26−$0.29
187180463733292626

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.